Versant Venture Management’s Vivani Medical VANI Stock Holding History

Versant Venture Management’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-187,204	Closed	-$484K	–	13
2020 Q3	$484K	Hold	187,204	–	–	0.09%	11
2020 Q2	$550K	Hold	187,204	–	–	0.08%	12
2020 Q1	$559K	Sell	187,204 -3	-0%	-$40	0.15%	9
2019 Q4	$3.34M	Hold	187,207	–	–	1.01%	5
2019 Q3	$3.71M	Hold	187,207	–	–	1.43%	6
2019 Q2	$3.6M	Hold	187,207	–	–	1.05%	7
2019 Q1	$3.57M	Hold	187,207	–	–	1.18%	6
2018 Q4	$3.98M	Hold	187,207	–	–	1.97%	6
2018 Q3	$8.54M	Hold	187,207	–	–	2.9%	6
2018 Q2	$7.46M	Hold	187,207	–	–	2.33%	7
2018 Q1	$8.63M	Hold	187,207	–	–	2.76%	6
2017 Q4	$8.58M	Hold	187,207	–	–	9.03%	6
2017 Q3	$5.39M	Hold	187,207	–	–	4.1%	7
2017 Q2	$5.62M	Hold	187,207	–	–	4.42%	7
2017 Q1	$5.44M	Buy	+187,207	New	+$7.17M	3.95%	6

Other funds holding VANI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Versant Venture Management's VANI Position: Q4 2020 in Review

Versant Venture Management sold out of Vivani Medical (VANI) in Q4 2020, closing a stake of 187,204 shares — an estimated $484K sold.

Versant Venture Management first reported a position in VANI in Q1 2017 and held it in 15 quarters. The position peaked at $8.63M in Q1 2018. 22 funds tracked by Wall St. Rank hold VANI as of Q4 2020.

Versant Venture Management reported no remaining Vivani Medical position as of Q4 2020 after selling out during the quarter.
Versant Venture Management sold 187,204 Vivani Medical shares in Q4 2020, an estimated $484K.
Versant Venture Management first reported a position in Vivani Medical in Q1 2017 and held it in 15 quarters.
Versant Venture Management's Vivani Medical position peaked at $8.63M in Q1 2018.
22 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2020.

Based on Versant Venture Management's 13F filing for Q4 2020, filed 16 Feb 2021.